Search results

  • Full text

  • Document type

    • Publication year

  • Organisation

Results: 7
Number of items: 7
  • Open Access
    Minderman, M. (2024). Oncogenic signaling and mechanisms of immune evasion in aggressive B-cell lymphomas. [Thesis, fully internal, Universiteit van Amsterdam].
  • van Steen, A. C. I., Grönloh, M. L. B., Joosten, S., van Alphen, F., van den Biggelaar, M., Nolte, M. A., Spaargaren, M., van Buul, J. D., & Schoppmeyer, R. (2023). Endothelial ICAM-1 Adhesome Recruits CD44 for Optimal Transcellular Migration of Human CTLs. Journal of Immunology, 211(3), 377-388. https://doi.org/10.4049/jimmunol.2200761
  • Open Access
    Thus, Y. J. (2023). Combatting ibrutinib and venetoclax resistance in MCL and CLL: From CRISPR screens and genetic analyses towards improved treatment. [Thesis, fully internal, Universiteit van Amsterdam].
  • Open Access
    Joosten, S. P. J. (2021). HGF/MET and CD44 in intestinal cancer: Partners in tumorigenesis and therapy resistance. [Thesis, fully internal, Universiteit van Amsterdam].
  • Open Access
    Zeilstra, J. (2020). CD44 isoforms in intestinal cancer: Identity and functions. [Thesis, fully internal, Universiteit van Amsterdam].
  • Open Access
    van Andel, H. (2019). Wnt signaling in the pathogenesis of multiple myeloma. [Thesis, fully internal, Universiteit van Amsterdam].
  • Open Access
    Ren, Z. (2019). Heparan sulfate proteoglycans: key moderators of the interaction of multiple myeloma with the bone marrow niche. [Thesis, fully internal, Universiteit van Amsterdam].
Page of